Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Botulinum toxin A may help regrow hair in pattern baldness.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

A rare skin cancer was correctly diagnosed after surgery, highlighting the need for careful examination and follow-up.

Nanoparticles offer significant benefits over traditional chemotherapy for cancer treatment.

Anti-androgen therapy is crucial for treating cancer and hormone-related diseases, even with low testosterone levels.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

Ritlecitinib works well and is safe for treating alopecia areata.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

The lotion safely and effectively reduces unwanted hair growth.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Aumolertinib effectively controls lung cancer and improves quality of life.

Personalized hair care strategies are needed for Black cancer patients to prevent hair loss during chemotherapy.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

PTH-CBD agonists may help regrow hair after chemotherapy.

Dutasteride for hair loss can cause skin reactions like itchy red plaques.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.